Colorectal Cancer Incidence Rises Across All Age Groups, with Sharpest Gains in 45-to-49 Cohort

Key points

• Incidence rates for colorectal cancer rose to 38.3 per 100,000 in 2023, up from 36.7 in 2022, after a decline from 55.2 in 2000.
• The 45-to-49 age group experienced the sharpest increase, with rates climbing 12.76% annually from 2019 to 2023.
• Colorectal cancer is now the leading cause of cancer-related death for Americans under 50, having overtaken lung cancer in this demographic.
• National screening guidelines lowered the recommended starting age from 50 to 45, which may explain some of the detected increase in cases.
• Tumors in younger patients exhibit distinct biological features, including higher stromal cell proportions, which may contribute to treatment resistance.

Background

Recent coverage has highlighted that colorectal cancer has become the second leading cause of cancer death in the US, with 55,230 deaths expected this year. While incidence rates have dropped for older adults, they have nearly doubled for those under 50. Experts have previously linked this shift to environmental factors and diet, urging earlier screening to detect preventable polyps. Additionally, recent research indicates that specific ultra-processed foods, rather than total intake, may influence cancer risk, with ultra-processed meat linked to higher risk.

How outlets are covering it

USA Today emphasizes the broadening trend of rising incidence across all age groups up to 69, attributing the sharp increase in the 45-to-49 cohort largely to expanded screening efforts. In contrast, Live Science and the Nature Medicine study focus on the biological distinctiveness of early-onset cancer, noting that tumors in younger patients have higher stromal cell proportions and unique RNA activity, which may make them more aggressive and resistant to treatment. While USA Today suggests screening is catching cancer earlier, the other sources argue that the disease itself is biologically different in younger patients, potentially explaining why survival rates do not improve despite more aggressive treatment.

Why it matters

The rising incidence across all age groups suggests that the factors driving colorectal cancer may be affecting the entire population, not just younger adults. This trend underscores the need for continued screening efforts and further research into the biological and environmental drivers of the disease. Understanding the distinct nature of early-onset cancer could lead to more effective treatments and prevention strategies for all age groups.

What to watch

Researchers are continuing to investigate the biological differences between early-onset and average-onset colorectal cancer, with a focus on the role of stromal cells and long noncoding RNA. Additionally, public health officials are likely to monitor the impact of the lowered screening age on overall incidence rates and mortality. Further studies may explore the role of diet and environmental factors in driving the rise in colorectal cancer across all age groups.